Milestone Pharmaceuticals VP holds 100K-share option
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Milestone Pharmaceuticals Inc. Vice President, Finance Anthony J. Krick directly holds an employee share option covering 100,000 common shares, with an exercise price of $1.32 and an expiration date of July 1, 2036. One-fourth of the option shares vest May 7, 2027; one thirty-sixth of the remaining shares vest monthly thereafter, subject to continued service.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Employee Share Option (right to buy) F1 | -- | -- | -- |
Footnotes (1)
- F1. One-fourth (1/4th) of the shares subject to the option vest on May 7, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Key Figures
Key Terms
exercise price technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the terms of Anthony J. Krick’s MIST option?
AI-generated analysis. How Rhea-AI works. Not financial advice.